Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Biomed Chromatogr ; 34(2): e4744, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31725908

RESUMO

We proposed a biochemometrics strategy for tracing diuretic components of herbs based on quantitative determination and pharmacological evaluation. First, a sensitive and robust liquid chromatography coupled with tandem mass spectrometry approach was established for simultaneous quantification of six major triterpenoids in crude and salt-processed Alisma orientale. The separation of triterpenoids was achieved on a BEH C18 column with a mobile phase consisting of acetonitrile and water spiked with 0.1% formic acid. Six major triterpenoids were detected by multiple reaction monitoring in the negative ion mode. Glycyrrhetinic acid was used as the internal standard. The approach showed good linearity. Intra- and inter-day precisions were all within 2.9%. The recovery rates of each triterpenoid ranged from 97.9% to 103.2%. The approach was then successfully employed for quantitative analysis of six triterpenoids in ten batches of crude and salt-processed A. orientale. Second, the diuretic effects of crude and salt-processed A. orientale were evaluated in mice. Third, principal component analysis and canonical correlation analysis were used to uncover the relationship between the contents of six major triterpenoids and the diuretic effect of different crude and salt-processed samples. Alisol B, alisol F, and alisol A have a close positive correlation with the diuretic effect.


Assuntos
Alisma/química , Diuréticos , Extratos Vegetais/química , Animais , Cromatografia Líquida , Diuréticos/química , Diuréticos/farmacologia , Diuréticos/urina , Limite de Detecção , Modelos Lineares , Masculino , Camundongos , Reprodutibilidade dos Testes , Espectrometria de Massas em Tandem , Triterpenos/química , Triterpenos/farmacologia , Triterpenos/urina , Micção/efeitos dos fármacos
2.
Drug Test Anal ; 11(3): 512-522, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30194914

RESUMO

Diuretic agents are prohibited in sports in- and out-of-competition according to the regulations of the World Anti-Doping Agency (WADA) because of their possible masking effects on other doping agents in urine samples, and their ability to produce fast acute weight losses. Despite previous studies reported adverse analytical findings (AAFs) resulting from contaminations at ppm level (µg/g) of medicinal products, and recommended to introduce reporting limits for diuretics in doping controls, these are not adopted in analyses performed by WADA-accredited laboratories. We report the case of an athlete with two AAFs for hydrochlorothiazide (HCTZ) at low urinary concentrations (<10 ng/mL), who declared the use of nutritional supplements prepared in a compounding pharmacy. His nutritional supplements were analyzed revealing HCTZ presence in different concentrations, at the ppm level (µg/g and ng/mL). With the aim of testing the plausibility of the observed urinary HCTZ concentrations with the nutritional supplement ingestion, a urinary excretion study with three healthy volunteers was performed. HCTZ-contaminated powder (6.4 µg/g of HCTZ) was administered to each subject in different dosages, reproducing the possible ingestion pattern occurred. Urine specimens were collected before and after ingestion of the powder, up to 24 hours, and underwent liquid-liquid extraction and liquid chromatography-tandem mass spectrometry determination. Post-administration specimens were found to contain HCTZ at concentrations of 5-230 ng/mL, which supported the accidental inadvertent intake of the prohibited substance by the athlete. This study makes the argument that the introduction of reporting limits for diuretics are warranted in doping control samples, in order to protect against inadvertent AAFs due to contaminated products.


Assuntos
Suplementos Nutricionais/análise , Contaminação de Medicamentos , Hidroclorotiazida/urina , Detecção do Abuso de Substâncias/métodos , Adulto , Cromatografia Líquida , Diuréticos/análise , Diuréticos/urina , Dopagem Esportivo/legislação & jurisprudência , Voluntários Saudáveis , Humanos , Hidroclorotiazida/análise , Legislação de Medicamentos/normas , Extração Líquido-Líquido , Masculino , Pós/química , Espectrometria de Massas em Tandem
3.
Artigo em Inglês | MEDLINE | ID: mdl-24146462

RESUMO

This present work describes an effective new method for study traditional Chinese medicine (TCM) on meridian tropism (MT) theory, which plays an essential role in clinical selection of TCM according to syndromes and strengthens the therapeutic effects. The new thread included material basis foundation and its tissue distribution study. Xiheliu, the most popular TCM on heart tropism, was investigated by simple and accurate high performance liquid chromatography (HPLC) method. The analysis of plasma after oral administration the total flavonoid of Xiheliu (TFX) exhibited that tamarixetin and kaempferide had the highest concentration and approximately the highest level within 25 min. The mixture of them could last accelerating the urine excretion more than 7 h after a single dose and could not cause the disorder of ion in rats, which was observed in diuretic activity experiment. In view of the reported biological activities was consistent with the effects of Xiheliu, tamarixetin and kaempferide were likely to be the material basis of it. Tissue distribution study showed that the highest level of analytes was in heart, lung, kidney and liver, and most tissues reached maximum level at 30 min post-dose. Since liver was the most important blood-supply tissue, the result of this experiment was in accordance with the MT record of Xiheliu and confirmed that tamarixetin and kaempferide was the material bases of it on MT. This is the first report for the illumination of material basis and the mechanism of Xiheliu on MT by analysis the record of Xiheliu in Compendium of Materia Medica and experimental study.


Assuntos
Dissacarídeos/farmacocinética , Medicamentos de Ervas Chinesas/farmacocinética , Quempferóis/farmacocinética , Medicina Tradicional Chinesa/métodos , Quercetina/análogos & derivados , Tamaricaceae/química , Administração Oral , Animais , Cromatografia Líquida de Alta Pressão , Dissacarídeos/urina , Diuréticos/farmacocinética , Diuréticos/urina , Coração , Íons/metabolismo , Quempferóis/urina , Masculino , Meridianos , Quercetina/farmacocinética , Quercetina/urina , Ratos , Ratos Wistar , Distribuição Tecidual , Tropismo
4.
J Anal Toxicol ; 31(9): 601-4, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18093421

RESUMO

Bumetanide is a loop diuretic used clinically to treat heart failure, acute renal failure, high blood pressure, and edema. However, diuretics may also be used by athletes as masking agents and to decrease weight. Taken as masking agents, diuretics increase urine production and decrease urinary concentrations of banned performance-enhancing agents, such as anabolic steroids. StarCaps is an over-the-counter dietary supplement marketed as a diet aid. The manufacturer claims that the product contains only natural cleansing agents and emphasizes that it is free from traditional appetite suppressants such as sympathomimetic amines. However, no such disclaimer is made concerning diuretic agents. A single StarCaps capsule was administered to two male and two female volunteers, and their urine specimens were collected at discrete intervals (2, 4, 8, and 12 h) post administration. The specimens were analyzed by a high-performance liquid chromatography-mass spectrometry quadrupole (HPLC-MS) method, and bumetanide was detected in all specimens (4.6 to 351.3 ng/mL). Adjusting the bumetanide concentrations for creatinine content did little to normalize the excretion profiles. Bumetanide was also detected in the StarCaps capsules at concentrations approaching therapeutic doses. HPLC-quadrupole-time-of-flight mass spectrometry was used to confirm the presence of bumetanide in the urine samples and StarCaps capsules. The results showed that unregulated dietary supplements may put consumers at risk for unwitting consumption of prescription medications, and that it is possible for athletes to inadvertently test positive for bumetanide and face disciplinary actions.


Assuntos
Bumetanida/urina , Suplementos Nutricionais , Diuréticos/urina , Adulto , Bumetanida/farmacocinética , Cromatografia Líquida de Alta Pressão , Diuréticos/farmacocinética , Feminino , Humanos , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade
5.
Ceylon Med J ; 51(3): 93-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17315585

RESUMO

OBJECTIVE: To investigate the diuretic, natriuretic and kaliuretic effects of the antihypertensive Ayurveda drug Karavi Panchaka decoction and compare it with the diuretic frusemide. DESIGN: An animal study using Sprague-Dawley rats. The volume of urine and the total sodium and potassium excreted in the urine by rats in response to orally fed Karavi Panchaka decoction were compared with rats fed with frusemide. Control experiments were done with rats receiving similar volumes of distilled water orally. The Ayurveda drug was prepared in accordance with the traditional method in the laboratory using medicinal plant specimens individually collected and identified. MEASUREMENTS: The volume of urine excreted during a 24-hour period following administration of the Ayurveda drug, frusemide or water was measured. The total sodium and potassium ion concentrations in the urine samples were determined using flame photometry. RESULTS: The Karavi Panchaka decoction clearly showed a statistically significant increase in urine excretion when compared with the control group that received only distilled water. The potassium ion excretion was significantly increased in the Karavi Panchaka decoction treated group when compared to the control group. This increase was statistically similar to that caused by frusemide. Neither drug had a significant effect on sodium ion excretion at the dosages used. CONCLUSION: Our results show that the Karavi Panchaka decoction significantly increases urine and potassium ion excretion in rats, but has no effect on sodium ion excretion at the dosage used. The effect of the Ayurveda drug on urine output as well as the sodium and potassium ion excretion is similar to that of frusemide administered at the dose used in our study.


Assuntos
Anti-Hipertensivos/farmacologia , Diuréticos/farmacologia , Furosemida/farmacologia , Ayurveda , Extratos Vegetais/farmacologia , Animais , Anti-Hipertensivos/urina , Diuréticos/urina , Furosemida/urina , Extratos Vegetais/urina , Potássio/urina , Ratos , Ratos Sprague-Dawley , Sódio/urina , Urina
6.
Kidney Blood Press Res ; 20(4): 240-6, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9398029

RESUMO

The tubular site of furosemide (F) action was studied by the technique of diuretic microinjection (MIJ) into proximal tubules of the rat nephron. F was injected into the last proximal superficial loop of 51 proximal tubules, at the concentration of 3 x 10(-4) mol/l in an infusate that contained 14C-inulin. Collections were performed at the early distal tubule before and after MIJ. Single nephron filtration rate (SNGFR) remained unchanged, while the percent of filtered volume reabsorbed up to the site of collection was 85+/-2 before, 79+/-2% after MIJ, p < 0.005. The calculated concentration of F in the collected distal tubular fluid during the post-MIJ measurements averaged 3 x 10(-5) mol/l. This experiment was repeated by injecting F into the early proximal convolutions of 43 nephrons, while the collections were performed at the last proximal segments. In these studies of proximal volume absorption, SNGFR was 34+/-3 before, 35+/-4 nl/min after F (p > 0.6). The respective percent reabsorptions were 70+/-3 and 73+/-3% (p +/- 0.3). In order to determine whether the technique per se was suitable to detect changes in reabsorption, the proximal MIJ study was repeated by using the carbonic anhydrase inhibitor dichlorphenamide 3 x 10(-5) mol/l in the microinjectate: while SNGFR remained unchanged, percent reabsorption fell from 63+/-5 to 45+/-7% during injection of the diuretic, p < 0.03. We conclude that the technique is adequate to examine the effects of drugs, and that F does not reduce proximal volume absorption at concentrations of 3 x 10(-5) mol/l. The loop diuretic decreases distal volume absorption by abolishing the osmotic gradient between blood and tubular fluid along the early distal convoluted tubule.


Assuntos
Diuréticos/farmacologia , Furosemida/farmacologia , Néfrons/efeitos dos fármacos , Animais , Transporte Biológico/efeitos dos fármacos , Diuréticos/urina , Avaliação Pré-Clínica de Medicamentos , Furosemida/urina , Taxa de Filtração Glomerular , Microinjeções , Ratos , Ratos Wistar
7.
An Med Interna ; 13(10): 496-9, 1996 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-9019198

RESUMO

We describe a 39 years old patient with a history of chronic symptomatic hypokalemia. She denied taking any drugs. She satisfied the clinical criteria for Bartter's syndrome and more precisely for Gitelman's syndrome: hypokalemia in the presence of inappropriately high potassium excretion, metabolic alkalosis, hyperreninemic hyperaldosteronism, hypomagnesemia with inappropriately high magnesium excretion, normocalcemia, hypocalciuria and normal blood pressure. A HPLC analysis detected the presence of furosemide in urine and chlorthalidone in urine and plasma samples. After the self administration of diuretics was stopped, the above alterations came back to normality. Prior to the verification of a self administration of diuretics, the patient showed clinical and biochemical parameters that oriented to surreptitious diuretic ingestion (Pseudo-Bartter's syndrome) not to Bartter's syndrome or Gitelman's syndrome, particularly the plasma potassium readily restored to normal by the administration of potassium chloride supplements, the increased plasma uric acid with low uric acid fractional clearance, the widely different urine and plasma electrolyte levels and the presence psychiatric disorders. The literature is reviewed and differential diagnosis, among this three syndromes, is made.


Assuntos
Síndrome de Bartter/diagnóstico , Diuréticos/administração & dosagem , Transtornos Autoinduzidos , Hipopotassemia/diagnóstico , Automedicação , Adulto , Clortalidona/efeitos adversos , Clortalidona/sangue , Clortalidona/urina , Cromatografia Líquida de Alta Pressão , Diagnóstico Diferencial , Diuréticos/efeitos adversos , Diuréticos/sangue , Diuréticos/urina , Feminino , Furosemida/efeitos adversos , Furosemida/urina , Humanos , Hipopotassemia/induzido quimicamente
8.
Pediatr Nephrol ; 9(6): 749-50, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8747119

RESUMO

A 4.5-year-old boy was admitted to three different hospitals because of a tendency towards dehydration and polyuria, along with normal blood pressure, hypochloraemia, hypokalaemia, metabolic alkalosis and an impaired urinary concentrating ability. A renal biopsy failed to reveal juxtaglomerular hyperplasia. The clinical and laboratory findings failed to improve despite supplementation with potassium chloride and treatment with indomethacin. The urine was found to contain frusemide. The parents denied any drug administration to the boy. The child is now doing well more than 1 year after separation from his mother. Since ingestion of diuretic cannot be differentiated from true Bartter syndrome by blood and urinary electrolyte measurements alone, a diuretic screen is warranted in children with findings consistent with Bartter syndrome.


Assuntos
Síndrome de Bartter/diagnóstico , Diuréticos/intoxicação , Furosemida/intoxicação , Síndrome de Munchausen Causada por Terceiro/diagnóstico , Pré-Escolar , Diagnóstico Diferencial , Diuréticos/urina , Furosemida/urina , Humanos , Masculino
9.
Bol. cientif. Santiago Cuba ; 2(2): 39-50, abr.-jun. 1984. graf
Artigo em Espanhol | CUMED | ID: cum-13868

RESUMO

Se realiza un estudio del efecto diurético de la infusión de hojas frescas de Alternanthera peploide en ratas albinas estableciéndose el volumen de orina excretado en 24 horas. Se determinan la composisción electrolítica de la orina y el plasma y algunas otras características físico-químicas de la orina. Luego del análisis estadístico de los resultados se elaboran gráficos y cuadros, donde se pone de manifiesto la actividad estimulante de la secreción urinaria por la planta en estudio(AU)


Assuntos
Animais , Ratos , Plantas Medicinais , Diuréticos/urina , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA